Ochsner Health System
Quick facts
Marketed products
- Ambrisentan Pill
- Furosemide plus Chlorothiazide · Cardiovascular
This combination of two loop and thiazide diuretics works by inhibiting sodium and chloride reabsorption in the kidney to increase urine output and reduce fluid overload. - intravenous NAC
- Slow Infusion of Rubidium-82 · Cardiovascular
Rubidium-82 is a positron-emitting radioactive tracer that accumulates in myocardial tissue proportional to blood flow, allowing visualization of cardiac perfusion defects via PET imaging.
Phase 2 pipeline
- HyperAcute vaccine · Immunology
The HyperAcute vaccine works by stimulating the body's immune system to recognize and fight specific diseases. - treprostinil dienthanolmine sustained release
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Ochsner Health System
What are Ochsner Health System's marketed drugs?
Top marketed products include Ambrisentan Pill, Furosemide plus Chlorothiazide, intravenous NAC, Slow Infusion of Rubidium-82.
Related
- Ambrisentan Pill
- Furosemide plus Chlorothiazide · Cardiovascular
- intravenous NAC
- Slow Infusion of Rubidium-82 · Cardiovascular
- Sector hub: All tracked pharma companies